お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はポイントオブケア感染症診断薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはポイントオブケア感染症診断薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のポイントオブケア感染症診断薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはポイントオブケア感染症診断薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にポイントオブケア感染症診断薬市場を分類しています。本研究に含まれる主な企業は：Thermo Fisher Scientific、Abbott、Calypte Biomedical、Chembio Diagnostic Systems、Meridian Bioscience、MedMira、Trinity Biotech、Sekisui Diagnostics、OraSure Technologies、Quidel

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    HIV POC
    Clostridium Difficile POC
    HBV POC
    Respiratory Syncytial Virus POC
    HPV POC
    Influenza/Flu POC
    HCV POC
    MRSA POC
    TB and Drug-Resistant TB POC

用途別の市場セグメント：
    Hospitals
    Clinics
    Home
    Assisted Living Healthcare Facilities
    Laboratories
    Others

本レポートの詳細内容
世界のポイントオブケア感染症診断薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、ポイントオブケア感染症診断薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のポイントオブケア感染症診断薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のポイントオブケア感染症診断薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、ポイントオブケア感染症診断薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

ポイントオブケア感染症診断薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：ポイントオブケア感染症診断薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：ポイントオブケア感染症診断薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章ポイントオブケア感染症診断薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：ポイントオブケア感染症診断薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：ポイントオブケア感染症診断薬の主要企業の概要を提供し、製品の説明と仕様、ポイントオブケア感染症診断薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.

Market Analysis and Insights: Global Point-of-care Infectious Disease Diagnostics Market
The global Point-of-care Infectious Disease Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Point-of-care Infectious Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Point-of-care Infectious Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Point-of-care Infectious Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point-of-care Infectious Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-care Infectious Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Point-of-care Infectious Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics and OraSure Technologies, etc.

Market Segmentation
By Company
    Thermo Fisher Scientific
    Abbott
    Calypte Biomedical
    Chembio Diagnostic Systems
    Meridian Bioscience
    MedMira
    Trinity Biotech
    Sekisui Diagnostics
    OraSure Technologies
    Quidel

Segment by Type
    HIV POC
    Clostridium Difficile POC
    HBV POC
    Respiratory Syncytial Virus POC
    HPV POC
    Influenza/Flu POC
    HCV POC
    MRSA POC
    TB and Drug-Resistant TB POC

Segment by Application
    Hospitals
    Clinics
    Home
    Assisted Living Healthcare Facilities
    Laboratories
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Point-of-care Infectious Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point-of-care Infectious Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of HIV POC
    Table 3. Key Players of Clostridium Difficile POC
    Table 4. Key Players of HBV POC
    Table 5. Key Players of Respiratory Syncytial Virus POC
    Table 6. Key Players of HPV POC
    Table 7. Key Players of Influenza/Flu POC
    Table 8. Key Players of HCV POC
    Table 9. Key Players of MRSA POC
    Table 10. Key Players of TB and Drug-Resistant TB POC
    Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2019-2024)
    Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2025-2030)
    Table 17. Point-of-care Infectious Disease Diagnostics Market Trends
    Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers
    Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges
    Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints
    Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 22. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players (2019-2024)
    Table 23. Global Top Point-of-care Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2023)
    Table 24. Global Point-of-care Infectious Disease Diagnostics Industry Ranking 2022 VS 2023 VS 2024
    Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 26. Global Key Players of Point-of-care Infectious Disease Diagnostics, Headquarters and Area Served
    Table 27. Global Key Players of Point-of-care Infectious Disease Diagnostics, Product and Application
    Table 28. Global Key Players of Point-of-care Infectious Disease Diagnostics, Product and Application
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2019-2024)
    Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2025-2030)
    Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2019-2024)
    Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2025-2030)
    Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. North America Point-of-care Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Europe Point-of-care Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 50. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 51. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 52. China Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 53. China Point-of-care Infectious Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 54. China Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 55. China Point-of-care Infectious Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Asia Point-of-care Infectious Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Asia Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Asia Point-of-care Infectious Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Asia Point-of-care Infectious Disease Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Asia Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 62. Asia Point-of-care Infectious Disease Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 68. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 69. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 70. Thermo Fisher Scientific Company Details
    Table 71. Thermo Fisher Scientific Business Overview
    Table 72. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product
    Table 73. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 74. Thermo Fisher Scientific Recent Developments
    Table 75. Abbott Company Details
    Table 76. Abbott Business Overview
    Table 77. Abbott Point-of-care Infectious Disease Diagnostics Product
    Table 78. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 79. Abbott Recent Developments
    Table 80. Calypte Biomedical Company Details
    Table 81. Calypte Biomedical Business Overview
    Table 82. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product
    Table 83. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 84. Calypte Biomedical Recent Developments
    Table 85. Chembio Diagnostic Systems Company Details
    Table 86. Chembio Diagnostic Systems Business Overview
    Table 87. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product
    Table 88. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 89. Chembio Diagnostic Systems Recent Developments
    Table 90. Meridian Bioscience Company Details
    Table 91. Meridian Bioscience Business Overview
    Table 92. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product
    Table 93. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 94. Meridian Bioscience Recent Developments
    Table 95. MedMira Company Details
    Table 96. MedMira Business Overview
    Table 97. MedMira Point-of-care Infectious Disease Diagnostics Product
    Table 98. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 99. MedMira Recent Developments
    Table 100. Trinity Biotech Company Details
    Table 101. Trinity Biotech Business Overview
    Table 102. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product
    Table 103. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 104. Trinity Biotech Recent Developments
    Table 105. Sekisui Diagnostics Company Details
    Table 106. Sekisui Diagnostics Business Overview
    Table 107. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product
    Table 108. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 109. Sekisui Diagnostics Recent Developments
    Table 110. OraSure Technologies Company Details
    Table 111. OraSure Technologies Business Overview
    Table 112. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product
    Table 113. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 114. OraSure Technologies Recent Developments
    Table 115. Quidel Company Details
    Table 116. Quidel Business Overview
    Table 117. Quidel Point-of-care Infectious Disease Diagnostics Product
    Table 118. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
    Table 119. Quidel Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. HIV POC Features
    Figure 4. Clostridium Difficile POC Features
    Figure 5. HBV POC Features
    Figure 6. Respiratory Syncytial Virus POC Features
    Figure 7. HPV POC Features
    Figure 8. Influenza/Flu POC Features
    Figure 9. HCV POC Features
    Figure 10. MRSA POC Features
    Figure 11. TB and Drug-Resistant TB POC Features
    Figure 12. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 13. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2023 VS 2030
    Figure 14. Hospitals Case Studies
    Figure 15. Clinics Case Studies
    Figure 16. Home Case Studies
    Figure 17. Assisted Living Healthcare Facilities Case Studies
    Figure 18. Laboratories Case Studies
    Figure 19. Others Case Studies
    Figure 20. Point-of-care Infectious Disease Diagnostics Report Years Considered
    Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2023 VS 2030
    Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2023
    Figure 25. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2023)
    Figure 26. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2023
    Figure 27. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Share by Type (2019-2030)
    Figure 29. North America Point-of-care Infectious Disease Diagnostics Market Share by Application (2019-2030)
    Figure 30. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)
    Figure 31. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. Europe Point-of-care Infectious Disease Diagnostics Market Share by Type (2019-2030)
    Figure 35. Europe Point-of-care Infectious Disease Diagnostics Market Share by Application (2019-2030)
    Figure 36. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)
    Figure 37. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Point-of-care Infectious Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 44. China Point-of-care Infectious Disease Diagnostics Market Share by Type (2019-2030)
    Figure 45. China Point-of-care Infectious Disease Diagnostics Market Share by Application (2019-2030)
    Figure 46. Asia Point-of-care Infectious Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Asia Point-of-care Infectious Disease Diagnostics Market Share by Type (2019-2030)
    Figure 48. Asia Point-of-care Infectious Disease Diagnostics Market Share by Application (2019-2030)
    Figure 49. Asia Point-of-care Infectious Disease Diagnostics Market Share by Region (2019-2030)
    Figure 50. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. China Taiwan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 57. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Share by Type (2019-2030)
    Figure 58. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Share by Application (2019-2030)
    Figure 59. Middle East, Africa, and Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2019-2030)
    Figure 60. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 64. Israel Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 65. GCC Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 67. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 68. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 69. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 70. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 71. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 72. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 73. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 74. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 75. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed